What is ArcticZymes Technologies ASA (AZT.OL)?

ArcticZymes Technologies ASA (AZT.OL) is a stock in the Healthcare sector, Biotechnology industry. View full analysis on Stocks360.

ArcticZymes Technologies ASA (AZT.OL)

Stock analysis · OSL · Healthcare · Biotechnology

Market Cap

N/A

PE (TTM)

N/A

EPS (TTM)

N/A

Dividend Yield

N/A

Beta

0.57

Day Range

N/A

52-wk Range

N/A

Avg Volume

N/A

Volume

N/A

ArcticZymes Technologies ASA (AZT.OL) is a publicly traded company in the Healthcare sector. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Earnings

Most Recent

Aug 14, 2026

EPS $0.10 vs est. $0.10

Missed by $0.01

Proprietary Signals

Signal snapshot temporarily unavailable.

About ArcticZymes Technologies ASA

ArcticZymes Technologies ASA is a leading life sciences firm dedicated to the development, production, and global sale of recombinant enzymes. These specialized enzymes are essential for a variety of applications, including molecular research, in vitro diagnostic testing, and processes within biomanufacturing. The company's diverse product lineup includes several key enzymatic solutions. For example, its salt active nuclease is instrumental in eliminating nucleic acids during the manufacturing of viral vectors, recombinant proteins, and other critical reagents. ArcticZymes also supplies shrimp alkaline phosphatase and accompanying kits, which are vital for purifying samples before both Sanger and next-generation sequencing. Another significant product is cod UNG, frequently utilized in viral and other molecular diagnostic assays, alongside double-strand specific DNases and their related kits, engineered for the efficient removal of double-stranded DNA. The firm's polymerases are designed to drive technological progress in life science, molecular diagnostics, NGS, and synthetic biology. Furthermore, it offers proteinase for applications in microbiological diagnostics and liquid bio…